Margaret Feltz

Chief Ethics & Compliance Officer

Margaret K. Feltz, Esq. is a Vice President and the Chief Ethics & Compliance Officer at Purdue Pharma. She also serves as a member of the Purdue Pharma’s Executive Committee. Feltz is responsible for the Company’s overall ethics and compliance strategy and leadership, technical direction and guidance concerning Purdue business activities, decisions and operations. Her team focuses on mitigating risk, advancing compliance with federal and state laws and Company policy, and ensuring that Purdue Pharma’s activities are consistent with high ethical standards.

Feltz began her career with Purdue Pharma in 2004, as a Senior Manager in the company’s compliance program. Prior to joining Purdue Pharma, Feltz worked as a healthcare attorney at McDermott, Will & Emery and later as Compliance Counsel for Boehringer Ingelheim Pharmaceuticals, Inc. Feltz was a long-standing co-chair and remains an active member of the Pharmaceutical Compliance Forum, a leading industry group representing nearly 60 research-based pharmaceutical manufacturers and supporting best practices sharing in pharmaceutical ethics and compliance.

Feltz received her Juris Doctor degree, cum laude, from Case Western Reserve University School of Law and her Master of Arts degree in Bioethics, magna cum laude, from Case Western Reserve University School of Medicine. Feltz earned a Bachelor of Arts degree from Wellesley College, where she majored in bioethics with a concentration in biology.

Leadership page

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.